Key result
Radially aligned PCL/PGS/PSf scaffolds enhance HUVEC viability and alignment for heart valve tissue engineering.
Why the study?
Current heart valve substitutes face limitations including thrombogenicity, limited durability, and lack of remodeling, while mimicking native anisotropic leaflet architecture remains a challenge in tissue engineering.
Radially aligned PCL/PGS/PSf nanofibrous scaffolds enhance endothelial cell viability and alignment, showing potential as a biomimetic construct for heart valve tissue engineering.
Answers are grounded in this paper and cite their sources.
May advance aligned nanofibrous scaffolds for valve engineering; leaves open in vivo durability and clinical translation.
Heart valve diseases (HVDs) are a major health issue and are significant causes of mortality worldwide. Despite technological developments, current valve substitutes still face major challenges such as thrombogenicity, limited durability, and lack of growth or remodeling capabilities. To handle the limitations of currently used valve prostheses, heart valve tissue engineering (HVTE) has become a viable option for generating biological valve alternatives. However, a major challenge when designing functional HVTE is mimicking the structural and anisotropic mechanical characteristics of the valve leaflets in their natural state. To achieve a biomimetic structure, this study aims to create an anisotropic microenvironment by focusing on the ventricularis layer of the leaflet. Through this approach, we reported the fabrication and characterization of a novel composite nanofibrous radial aligned scaffold consisting of polycaprolactone (PCL), poly(glycerol sebacate) (PGS), and anticoagulant polysulfone (PSf) polymers by combining 3D printing and electrospinning techniques. Radially aligned PCL/PGS/PSf scaffolds enhanced human umbilical vein endothelial cells (HUVECs) cell viability and induced alignment as shown from fluorescence microscopy analysis. Meeting the anisotropy requirements, the composite heart valves of PCL/PGS/PSf nanofibrous scaffolds would be a tissue engineering construct.
No takes yet. Share an insight, caveat, or question.
Gürbüz et al. (2024) studied Heart valve diseases. Radially aligned PCL/PGS/PSf nanofibrous scaffolds was evaluated on Cell viability and alignment of HUVECs. Radially aligned PCL/PGS/PSf nanofibrous scaffolds enhanced human umbilical vein endothelial cell viability and induced alignment for heart valve tissue engineering.
Synapse has enriched 10 related papers. Consider them for comparative context: